Thus, a lower IGF-1 level can lead to a higher FOXO3 activity via the PI3K/AKT pathway, causing protein degradation and skeletal muscle atrophy [19], thereby resulting in the onset of sarcopenia in older adults. The gene discussed is IGF1; the disease is sarcopenia.